North America Upstream Bioprocessing Market
No. of Pages: 127 | Report Code: BMIRE00030683 | Category: Life Sciences
No. of Pages: 127 | Report Code: BMIRE00030683 | Category: Life Sciences
The North America upstream bioprocessing market was valued at US$ 3,958.62 million in 2022 and is expected to reach US$ 10,603.38 million by 2030; it is estimated to grow at a CAGR of 13.1% from 2022 to 2030. Commercial Use of Single-Use Bioreactors Fuels North America Upstream Bioprocessing Market.
Various manufacturers are developing single-use bioreactors (SUBs) due to their robust build and high performance, which are necessary for the commercial manufacturing of biopharmaceuticals. The incorporation of technologies associated with biofilm formation, stirring mechanisms, bioreactor designs, and sensor systems, among others, have resulted in the increased adoption of disposable reactors at the laboratory and production scales. Single-use bioreactors are operated to manufacture next-generation cell and gene therapies, and they are suitable for continuous bioprocessing. Advancements in cell-culture processes have developed higher titers and cell densities, facilitating the adoption of SUBs. Single-use bioreactors operate with a low risk of contamination, shorter production turnaround times, and reduced validation time. In the last few years, the use of single-use bioreactors has increased in modern biopharmaceutical processes owing to their unique ability to aid enhanced flexibility, reduce investments, and limit operational costs. Also, many companies have developed single-use bioreactors for producing a wide range of therapeutics. In March 2021, Thermo Fischer Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors. Sartorius AG offers a wide range of single-use bioreactors. The company provides ambr 15 for a 10-15 mL micro bioreactor scale and Biostat STR for 50-2000L. The use of single-use bioreactors is subsequently increasing in upstream bioprocessing. Thus, the increasing acceptance of single-use bioreactors for the production of therapeutics propels the upstream bioprocessing market.North America Upstream Bioprocessing Market Overview
The upstream bioprocessing market in North America is segmented into the US, Canada, and Mexico. Market growth in North America is attributed to the increasing demand for bioreactor systems from biopharmaceutical and biotechnology companies, the prominent presence of market players, and growing R&D efforts by academic and research institutes. In addition, research activities by pharmaceutical and biotechnology companies propel the upstream bioprocessing market growth in North America.
North America Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million)
Strategic insights for the North America Upstream Bioprocessing provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the North America Upstream Bioprocessing refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Get more information on this report North America Upstream Bioprocessing Strategic Insights
Get more information on this report North America Upstream Bioprocessing Report Scope
Report Attribute
Details
Market size in 2022
US$ 3,958.62 Million
Market Size by 2030
US$ 10,603.38 Million
Global CAGR (2022 - 2030)
13.1%
Historical Data
2020-2021
Forecast period
2023-2030
Segments Covered
By Product Type
By Workflow
By Mode
Regions and Countries Covered
North America
Market leaders and key company profiles
Get more information on this report North America Upstream Bioprocessing Regional Insights
Get more information on this report North America Upstream Bioprocessing Market Segmentation
The North America upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country.
Based on product type, the North America upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022.
Based on workflow, the North America upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022.
In terms of usage type, the North America upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022
By mode, the North America upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022.
Based on country, the North America upstream bioprocessing market is segmented into the US, Canada, and Mexico. The US dominated the North America upstream bioprocessing market share in 2022.
Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Sartorius AG, Danaher Corp, Getinge AB, Merck KGaA, Corning Inc, Entegris Inc, and PBS Biotech Inc are some of the leading companies operating in the North America upstream bioprocessing market.
1. Thermo Fisher Scientific Inc
2. Esco Micro Pte Ltd
3. Sartorius AG
4. Danaher Corp
5. Getinge AB
6. Merck KGaA
7. Corning Inc
8. Entegris Inc
9. PBS Biotech Inc-NA.
The North America Upstream Bioprocessing Market is valued at US$ 3,958.62 Million in 2022, it is projected to reach US$ 10,603.38 Million by 2030.
As per our report North America Upstream Bioprocessing Market, the market size is valued at US$ 3,958.62 Million in 2022, projecting it to reach US$ 10,603.38 Million by 2030. This translates to a CAGR of approximately 13.1% during the forecast period.
The North America Upstream Bioprocessing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Upstream Bioprocessing Market report:
The North America Upstream Bioprocessing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Upstream Bioprocessing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Upstream Bioprocessing Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Upstream Bioprocessing Market
